Artelo Biosciences, Inc. Annual report pursuant to Section 13 and 15(d)

SUBSEQUENT EVENTS (Details Narrative) - USD ($)			1 Months Ended	12 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Jan. 05, 2024	Jan. 02, 2024	Feb. 28, 2024	Dec. 31, 2023
Stock issued				$ 38,741
Proceeds from stock issued				$ 55
Subsequent Event [Member]
Exercise price	$ 1.49		$ 1.99
Granted options to purchase common stock	92,000
Vesting Percentage	25.00%
Subsequent Event [Member] \| 2018 Equity Incentive Plan
Exercise price			$ 1.55
Granted options to purchase common stock		1,529,223
Granted option to purchase common stock		478,344